FDA Grants Approval for Cipla’s Generic Advair Diskus, Opening $908M U.S. Respiratory Market to Expanded Generic Competition
MUMBAI / WARREN, N.J. — In a landmark development for affordable respiratory care, pharmaceutical manufacturer Cipla Limited has secured regulatory...
India Approves Enhertu for Early-Stage HER2-Positive Breast Cancer Before Surgery: A New Paradigm in Pre-Operative Oncology
NEW DELHI — In a major expansion of targeted cancer therapies in South Asia, India’s drug regulator, the Central Drugs Standard Control Organisation...
Beyond Percentages: NMC Overhauls MBBS Admissions with Competency-Based Framework for Disabled Candidates
NEW DELHI — In a milestone shift for inclusive medical education, the National Medical Commission (NMC) notified landmark assessment guidelines on...
Navigating India’s Lifesaving Drug Price Balancing Act: How Regulatory Guardrails and Public Safety Nets Protect Patients
Published: July 28, 2026 NEW DELHI — In a formal written response submitted to the Rajya Sabha on July 28, 2026, the Union Ministry of Chemicals and...
India Overhauls Street Food Safety: FSSAI Waives Fees and Automates Licensing as Sampling Reveals Persistent Quality Gaps
NEW DELHI — In a major regulatory push to bring millions of informal vendors under official oversight, India’s apex food safety authority has issued...
